{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,22]],"date-time":"2026-08-22T23:22:37Z","timestamp":1787440957835,"version":"build-2736575974"},"reference-count":60,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T00:00:00Z","timestamp":1779321600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100010665","name":"EU Framework Programme for Research and Innovation Marie Sk\u0142odowska-Curie Actions","doi-asserted-by":"publisher","award":["860329"],"award-info":[{"award-number":["860329"]}],"id":[{"id":"10.13039\/100010665","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010665","name":"EU Framework Programme for Research and Innovation Marie Sk\u0142odowska-Curie Actions","doi-asserted-by":"publisher","award":["956851"],"award-info":[{"award-number":["956851"]}],"id":[{"id":"10.13039\/100010665","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004497","name":"KU Leuven Research Council","doi-asserted-by":"publisher","award":["1800820\\u2009N"],"award-info":[{"award-number":["1800820\\u2009N"]}],"id":[{"id":"10.13039\/501100004497","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"German Research Foundation","doi-asserted-by":"publisher","award":["505943254"],"award-info":[{"award-number":["505943254"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004040","name":"KU Leuven","doi-asserted-by":"publisher","award":["C14\/21\/103"],"award-info":[{"award-number":["C14\/21\/103"]}],"id":[{"id":"10.13039\/501100004040","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004040","name":"KU Leuven","doi-asserted-by":"publisher","award":["3M190551"],"award-info":[{"award-number":["3M190551"]}],"id":[{"id":"10.13039\/501100004040","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003130","name":"Fonds Wetenschappelijk Onderzoek","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003130","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010661","name":"Horizon 2020 Framework Programme","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010661","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine & Pharmacotherapy"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.biopha.2026.119581","type":"journal-article","created":{"date-parts":[[2026,5,28]],"date-time":"2026-05-28T17:10:33Z","timestamp":1779988233000},"page":"119581","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Kidney dysfunction regulates gut transporters"],"prefix":"10.1016","volume":"200","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9563-7757","authenticated-orcid":false,"given":"Mara","family":"Lauriola","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sander","family":"Dejongh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sebastian","family":"Steigert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ward","family":"Zadora","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophie","family":"Valkenburg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick","family":"Augustijns","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7641-4707","authenticated-orcid":false,"given":"Griet","family":"Glorieux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan","family":"Oswald","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7158-171X","authenticated-orcid":false,"given":"Ricard","family":"Farr\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bj\u00f6rn","family":"Meijers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.biopha.2026.119581_bib1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12967-018-1756-4","article-title":"Microbiome\u2013metabolome reveals the contribution of gut\u2013kidney axis on kidney disease","volume":"17","author":"Chen","year":"2019","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.biopha.2026.119581_bib2","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1007\/978-1-0716-1554-6_8","article-title":"The structure and mechanism of drug transporters","author":"Roberts","year":"2021","journal-title":"Enzym. Kinet. Drug Metab. Fundam. Appl."},{"issue":"3","key":"10.1016\/j.biopha.2026.119581_bib3","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1038\/nrd3028","volume":"9","author":"Membrane transporters in drug development","year":"2010","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.biopha.2026.119581_bib4","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1007\/s43440-020-00139-6","article-title":"Intestinal drug transporters in pathological states: An overview","volume":"72","author":"Drozdzik","year":"2020","journal-title":"Pharmacol. Rep."},{"issue":"6","key":"10.1016\/j.biopha.2026.119581_bib5","article-title":"P-glycoprotein: New insights into structure, physiological function, regulation and alterations in disease","volume":"8","author":"Juvale","year":"2022","journal-title":"Heliyon"},{"key":"10.1016\/j.biopha.2026.119581_bib6","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s40168-021-01137-3","article-title":"Gut microbiota regulation of P-glycoprotein in the intestinal epithelium in maintenance of homeostasis","volume":"9","author":"Foley","year":"2021","journal-title":"Microbiome"},{"issue":"30","key":"10.1016\/j.biopha.2026.119581_bib7","doi-asserted-by":"crossref","first-page":"18031","DOI":"10.1016\/S0021-9258(19)84675-6","article-title":"Modulation of the expression of a multidrug resistance gene (mdr-1\/P-glycoprotein) by differentiating agents","volume":"264","author":"Mickley","year":"1989","journal-title":"J. Biol. Chem."},{"issue":"4","key":"10.1016\/j.biopha.2026.119581_bib8","doi-asserted-by":"crossref","DOI":"10.1128\/mbio.01993-22","article-title":"Microbial metabolites orchestrate a distinct multi-tiered regulatory network in the intestinal epithelium that directs P-glycoprotein expression","volume":"13","author":"Foley","year":"2022","journal-title":"Mbio"},{"key":"10.1016\/j.biopha.2026.119581_bib9","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1471-230X-13-57","article-title":"MDR1 polymorphisms are associated with inflammatory bowel disease in a cohort of Croatian IBD patients","volume":"13","author":"Brinar","year":"2013","journal-title":"BMC Gastroenterol."},{"issue":"5","key":"10.1016\/j.biopha.2026.119581_bib10","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1093\/hmg\/ddi494","article-title":"ABCB1\/MDR1 gene determines susceptibility and phenotype in ulcerative colitis: discrimination of critical variants using a gene-wide haplotype tagging approach","volume":"15","author":"Ho","year":"2006","journal-title":"Hum. Mol. Genet."},{"issue":"1","key":"10.1016\/j.biopha.2026.119581_bib11","doi-asserted-by":"crossref","first-page":"G153","DOI":"10.1152\/ajpgi.00395.2004","article-title":"Epithelial dysfunction associated with the development of colitis in conventionally housed mdr1a\u2212\/\u2212 mice","volume":"289","author":"Resta-Lenert","year":"2005","journal-title":"Am. J. Physiol. -Gastrointest. Liver Physiol."},{"key":"10.1016\/j.biopha.2026.119581_bib12","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1385\/IR:31:2:151","article-title":"The mdr1a\u2212\/\u2212 mouse model of spontaneous colitis: a relevant and appropriate animal model to study inflammatory bowel disease","volume":"31","author":"Wilk","year":"2005","journal-title":"Immunol. Res."},{"issue":"3","key":"10.1016\/j.biopha.2026.119581_bib13","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1002\/ibd.20030","article-title":"Efflux transporters in ulcerative colitis decreased expression of BCRP (ABCG2) and Pgp (ABCB1)","volume":"13","author":"Englund","year":"2007","journal-title":"Inflamm. bowel Dis."},{"issue":"3","key":"10.1016\/j.biopha.2026.119581_bib14","first-page":"69","article-title":"Mechanisms of P-glycoprotein regulation under exogenous and endogenous oxidative stress in vitro","volume":"14","author":"Yu","year":"2022","journal-title":"Acta Nat. (\u0430\u043d\u0433\u043b\u043e\u044f\u0437\u044b\u0447\u043d\u0430\u044f \u0432\u0435\u0440\u0441\u0438\u044f)"},{"issue":"2","key":"10.1016\/j.biopha.2026.119581_bib15","doi-asserted-by":"crossref","first-page":"266","DOI":"10.18433\/J3JG7D","article-title":"Intestinal P-glycoprotein expression is multimodally regulated by intestinal ischemia-reperfusion","volume":"17","author":"Terada","year":"2014","journal-title":"J. Pharm. Pharm. Sci."},{"issue":"2","key":"10.1016\/j.biopha.2026.119581_bib16","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1002\/cpt.1998","article-title":"A Microdose Cocktail to Evaluate Drug Interactions in Patients with Renal Impairment","volume":"109","author":"Tatosian","year":"2021","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.biopha.2026.119581_bib17","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2021.726669","article-title":"Quantification of CYP3A and Drug Transporters Activity in Healthy Young, Healthy Elderly and Chronic Kidney Disease Elderly Patients by a Microdose Cocktail Approach","volume":"12","author":"Rattanacheeworn","year":"2021","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.biopha.2026.119581_bib18","doi-asserted-by":"crossref","DOI":"10.1016\/j.clnesp.2024.10.166","article-title":"Intestinal transport of organic food compounds and drugs: a systematic review on the alterations observed in chronic kidney disease","author":"Lauriola","year":"2024","journal-title":"Clin. Nutr. ESPEN"},{"issue":"12","key":"10.1016\/j.biopha.2026.119581_bib19","doi-asserted-by":"crossref","first-page":"2994","DOI":"10.1681\/ASN.2021070988","article-title":"A unifying approach for GFR estimation: recommendations of the NKF-ASN task force on reassessing the inclusion of race in diagnosing kidney disease","volume":"32","author":"Delgado","year":"2021","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.biopha.2026.119581_bib20","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.aca.2016.06.057","article-title":"A liquid chromatography\u2013tandem mass spectrometry method to measure a selected panel of uremic retention solutes derived from endogenous and colonic microbial metabolism","volume":"936","author":"de Loor","year":"2016","journal-title":"Anal. Chim. Acta"},{"issue":"3","key":"10.1016\/j.biopha.2026.119581_bib21","doi-asserted-by":"crossref","first-page":"F518","DOI":"10.1152\/ajprenal.00656.2020","article-title":"A plasma creatinine-and urea-based equation to estimate glomerular filtration rate in rats","volume":"320","author":"Besseling","year":"2021","journal-title":"Am. J. Physiol. -Ren. Physiol."},{"key":"10.1016\/j.biopha.2026.119581_bib22","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejps.2024.106821","article-title":"Characterization of luminal contents from the fasted human proximal colon","author":"Steigert","year":"2024","journal-title":"Eur. J. Pharm. Sci."},{"issue":"5","key":"10.1016\/j.biopha.2026.119581_bib23","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1002\/cpt.1301","article-title":"Protein abundance of clinically relevant drug transporters in the human liver and intestine: a comparative analysis in paired tissue specimens","volume":"105","author":"Drozdzik","year":"2019","journal-title":"Clin. Pharmacol. & Ther."},{"key":"10.1016\/j.biopha.2026.119581_bib24","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.jpba.2013.07.031","article-title":"LC\u2013MS\/MS-based quantification of clinically relevant intestinal uptake and efflux transporter proteins","volume":"85","author":"Gr\u00f6er","year":"2013","journal-title":"J. Pharm. Biomed. Anal."},{"issue":"14","key":"10.1016\/j.biopha.2026.119581_bib25","doi-asserted-by":"crossref","first-page":"4629","DOI":"10.3390\/molecules27144629","article-title":"Gene expression and protein abundance of nuclear receptors in human intestine and liver: a new application for mass spectrometry-based targeted proteomics","volume":"27","author":"Wenzel","year":"2022","journal-title":"Molecules"},{"issue":"8","key":"10.1016\/j.biopha.2026.119581_bib26","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1038\/s41587-019-0201-4","article-title":"Graph-based genome alignment and genotyping with HISAT2 and HISAT-genotype","volume":"37","author":"Kim","year":"2019","journal-title":"Nat. Biotechnol."},{"issue":"2","key":"10.1016\/j.biopha.2026.119581_bib27","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1093\/bioinformatics\/btu638","article-title":"HTSeq\u2014a Python framework to work with high-throughput sequencing data","volume":"31","author":"Anders","year":"2015","journal-title":"bioinformatics"},{"issue":"7","key":"10.1016\/j.biopha.2026.119581_bib28","doi-asserted-by":"crossref","DOI":"10.1186\/gb-2002-3-7-research0034","article-title":"Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes","volume":"3","author":"Vandesompele","year":"2002","journal-title":"Genome Biol."},{"issue":"2","key":"10.1016\/j.biopha.2026.119581_bib29","doi-asserted-by":"crossref","DOI":"10.1186\/gb-2007-8-2-r19","article-title":"qBase relative quantification framework and software for management and automated analysis of real-time quantitative PCR data","volume":"8","author":"Hellemans","year":"2007","journal-title":"Genome Biol."},{"issue":"6","key":"10.1016\/j.biopha.2026.119581_bib30","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.1016\/j.kint.2020.01.028","article-title":"Gut microbiota generation of protein-bound uremic toxins and related metabolites is not altered at different stages of chronic kidney disease","volume":"97","author":"Gryp","year":"2020","journal-title":"Kidney Int."},{"issue":"11","key":"10.1016\/j.biopha.2026.119581_bib31","doi-asserted-by":"crossref","first-page":"809","DOI":"10.3390\/toxins13110809","article-title":"Gut microbiota and their derived metabolites, a search for potential targets to limit accumulation of protein-bound uremic toxins in chronic kidney disease","volume":"13","author":"Steenbeke","year":"2021","journal-title":"Toxins"},{"issue":"1","key":"10.1016\/j.biopha.2026.119581_bib32","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-019-51640-9","article-title":"Uremic serum residue decreases SN-38 sensitivity through suppression of organic anion transporter polypeptide 2B1 in LS-180 colon cancer cells","volume":"9","author":"Ozawa","year":"2019","journal-title":"Sci. Rep."},{"issue":"2","key":"10.1016\/j.biopha.2026.119581_bib33","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1111\/jphp.12328","article-title":"In-vitro evidence of enhanced breast cancer resistance protein-mediated intestinal urate secretion by uremic toxins in Caco-2 cells","volume":"67","author":"Lu","year":"2015","journal-title":"J. Pharm. Pharmacol."},{"issue":"10","key":"10.1016\/j.biopha.2026.119581_bib34","doi-asserted-by":"crossref","first-page":"2269","DOI":"10.1681\/ASN.2009010082","article-title":"ESRD impairs nonrenal clearance of fexofenadine but not midazolam","volume":"20","author":"Nolin","year":"2009","journal-title":"J. Am. Soc. Nephrol."},{"issue":"6","key":"10.1016\/j.biopha.2026.119581_bib35","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1111\/j.1744-9987.2012.01100.x","article-title":"Influence of serum in hemodialysis patients on the expression of intestinal and hepatic transporters for the excretion of pravastatin","volume":"16","author":"Tsujimoto","year":"2012","journal-title":"Ther. Apher. Dial."},{"issue":"2","key":"10.1016\/j.biopha.2026.119581_bib36","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1021\/bi901786x","article-title":"The uremic toxin 3-indoxyl sulfate is a potent endogenous agonist for the human aryl hydrocarbon receptor","volume":"49","author":"Schroeder","year":"2010","journal-title":"Biochemistry"},{"issue":"3","key":"10.1016\/j.biopha.2026.119581_bib37","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1681\/ASN.2017030361","article-title":"Indoxyl sulfate upregulates liver P-glycoprotein expression and activity through aryl hydrocarbon receptor signaling","volume":"29","author":"Machado","year":"2018","journal-title":"J. Am. Soc. Nephrol."},{"issue":"8","key":"10.1016\/j.biopha.2026.119581_bib38","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1093\/ndt\/16.8.1607","article-title":"Effect of chronic renal failure on the expression and function of rat intestinal P-glycoprotein in drug excretion","volume":"16","author":"Veau","year":"2001","journal-title":"Nephrol. Dial. Transplant."},{"issue":"3","key":"10.1016\/j.biopha.2026.119581_bib39","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1124\/jpet.106.112631","article-title":"Down-regulation of intestinal drug transporters in chronic renal failure in rats","volume":"320","author":"Naud","year":"2007","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.biopha.2026.119581_bib40","doi-asserted-by":"crossref","DOI":"10.1016\/j.jep.2023.116818","article-title":"Comparative pharmacokinetics of six bioactive components of Shen-Wu-Yi-Shen tablets in normal and chronic renal failure rats based on UPLC-TSQ-MS\/MS","volume":"317","author":"Mei","year":"2023","journal-title":"J. Ethnopharmacol."},{"issue":"1","key":"10.1016\/j.biopha.2026.119581_bib41","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1080\/0886022X.2019.1602054","article-title":"The prominent impairment of liver\/intestinal cytochrome P450 and intestinal drug transporters in sepsis-induced acute kidney injury over acute and chronic renal ischemia, a mouse model comparison","volume":"41","author":"Sukkummee","year":"2019","journal-title":"Ren. Fail."},{"issue":"1","key":"10.1016\/j.biopha.2026.119581_bib42","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1124\/dmd.107.014845","article-title":"Gender differences in mRNA expression of ATP-binding cassette efflux and bile acid transporters in kidney, liver, and intestine of 5\/6 nephrectomized rats","volume":"36","author":"Lu","year":"2008","journal-title":"Drug Metab. Dispos."},{"issue":"3","key":"10.1016\/j.biopha.2026.119581_bib43","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0122399","article-title":"Gut microbiota and tacrolimus dosing in kidney transplantation","volume":"10","author":"Lee","year":"2015","journal-title":"PloS One"},{"issue":"1","key":"10.1016\/j.biopha.2026.119581_bib44","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1038\/s41598-018-37019-2","article-title":"Identification of the novel role of butyrate as AhR ligand in human intestinal epithelial cells","volume":"9","author":"Marinelli","year":"2019","journal-title":"Sci. Rep."},{"issue":"6","key":"10.1016\/j.biopha.2026.119581_bib45","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1007\/s00467-018-4005-4","article-title":"Oxidative stress in chronic kidney disease","volume":"34","author":"Daenen","year":"2019","journal-title":"Pedia Nephrol."},{"key":"10.1016\/j.biopha.2026.119581_bib46","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.tiv.2019.01.003","article-title":"Uremic solutes modulate hepatic bile acid handling and induce mitochondrial toxicity","volume":"56","author":"Weigand","year":"2019","journal-title":"Toxicol. Vitr."},{"issue":"24","key":"10.1016\/j.biopha.2026.119581_bib47","doi-asserted-by":"crossref","first-page":"23232","DOI":"10.1074\/jbc.M411520200","article-title":"Vitamin D receptor-dependent regulation of colon multidrug resistance-associated protein 3 gene expression by bile acids","volume":"280","author":"McCarthy","year":"2005","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.biopha.2026.119581_bib48","article-title":"Targeted metabolomics study of serum bile acid profile in patients with end-stage renal disease undergoing hemodialysis","volume":"7","author":"Li","year":"2019","journal-title":"PeerJ"},{"issue":"3","key":"10.1016\/j.biopha.2026.119581_bib49","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1080\/17425255.2020.1732348","article-title":"Transcription factor-mediated regulation of the BCRP\/ABCG2 efflux transporter: a review across tissues and species","volume":"16","author":"Gorczyca","year":"2020","journal-title":"Expert Opin. Drug Metab. & Toxicol."},{"issue":"26","key":"10.1016\/j.biopha.2026.119581_bib50","doi-asserted-by":"crossref","first-page":"17882","DOI":"10.1074\/jbc.M601302200","article-title":"Role of NF-\u03baB in regulation of PXR-mediated gene expression: a mechanism for the suppression of cytochrome P-450 3A4 by proinflammatory agents","volume":"281","author":"Gu","year":"2006","journal-title":"J. Biol. Chem."},{"issue":"4","key":"10.1016\/j.biopha.2026.119581_bib51","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1053\/j.ajkd.2014.09.015","article-title":"Effect of CKD and dialysis modality on exposure to drugs cleared by nonrenal mechanisms","volume":"65","author":"Thomson","year":"2015","journal-title":"Am. J. Kidney Dis."},{"key":"10.1016\/j.biopha.2026.119581_bib52","unstructured":"U.S. Food and Drug Administration. Drug development and drug interactions: table of substrates, inhibitors and inducers. Available from: https:\/\/www.fda.gov\/drugs\/drug-interactions-labeling\/drug-development-and-drug-interactions-table-substrates-inhibitors-and-inducers (accessed 28 Nov 2025)."},{"issue":"5","key":"10.1016\/j.biopha.2026.119581_bib53","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1111\/bcp.12654","article-title":"Sulfasalazine disposition in a subject with 376C> T (nonsense mutation) and 421C> A variants in the ABCG2 gene","volume":"80","author":"Gotanda","year":"2015","journal-title":"Br. J. Clin. Pharmacol."},{"issue":"12","key":"10.1016\/j.biopha.2026.119581_bib54","doi-asserted-by":"crossref","first-page":"3350","DOI":"10.1158\/1535-7163.MCT-09-0668","article-title":"Abcc2 (Mrp2), Abcc3 (Mrp3), and Abcg2 (Bcrp1) are the main determinants for rapid elimination of methotrexate and its toxic metabolite 7-hydroxymethotrexate in vivo","volume":"8","author":"Vlaming","year":"2009","journal-title":"Mol. Cancer Ther."},{"issue":"2","key":"10.1016\/j.biopha.2026.119581_bib55","doi-asserted-by":"crossref","first-page":"G371","DOI":"10.1152\/ajpgi.00102.2009","article-title":"Small intestinal efflux mediated by MRP2 and BCRP shifts sulfasalazine intestinal permeability from high to low, enabling its colonic targeting","volume":"297","author":"Dahan","year":"2009","journal-title":"Am. J. Physiol. -Gastrointest. Liver Physiol."},{"issue":"8","key":"10.1016\/j.biopha.2026.119581_bib56","first-page":"787","article-title":"Transport of glutathione conjugates and glucuronides by the multidrug resistance proteins MRP1 and MRP2","volume":"378","author":"Keppler","year":"1997","journal-title":"Biol. Chem."},{"issue":"2","key":"10.1016\/j.biopha.2026.119581_bib57","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1016\/j.xphs.2018.09.024","article-title":"Dysregulation of mucosal membrane transporters and drug-metabolizing enzymes in ulcerative colitis","volume":"108","author":"Erdmann","year":"2019","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.biopha.2026.119581_bib58","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2022.122282","article-title":"The impact of inflammation on the expression of drug transporters and metabolic enzymes in colonic tissue from ulcerative colitis patients","volume":"628","author":"de Waal","year":"2022","journal-title":"Int. J. Pharm."},{"issue":"10","key":"10.1016\/j.biopha.2026.119581_bib59","doi-asserted-by":"crossref","first-page":"3547","DOI":"10.1021\/mp500330y","article-title":"Protein abundance of clinically relevant multidrug transporters along the entire length of the human intestine","volume":"11","author":"Drozdzik","year":"2014","journal-title":"Mol. Pharm."},{"issue":"3","key":"10.1016\/j.biopha.2026.119581_bib60","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1124\/jpet.102.041236","article-title":"Region-dependent modulation of intestinal permeability by drug efflux transporters: in vitro studies in mdr1a (\u2212\/\u2212) mouse intestine","volume":"303","author":"Stephens","year":"2002","journal-title":"J. Pharmacol. Exp. Ther."}],"container-title":["Biomedicine & Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332226006177?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332226006177?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,22]],"date-time":"2026-08-22T22:59:31Z","timestamp":1787439571000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332226006177"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":60,"alternative-id":["S0753332226006177"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2026.119581","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Kidney dysfunction regulates gut transporters","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2026.119581","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"119581"}}